Opthea Ltd has released a press release.
Opthea Equity Raising Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Opthea
- Opthea Presentation for Ophthalmology Innovation Summit
- Opthea Receives A$14.6m R&D Tax Incentive
- Opthea Presentation for EURETINA Congress
- Opthea Ph2b of OPT-302 in wAMD to be Presented at EURETINA
- Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302
Later from Opthea
- Opthea Completes Recruitment in Ph2a Trial of OPT-302 in DME
- Opthea Completes Patient Dosing in Phase 2a DME Trial
- Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
- S&P DJI Announces June 2020 Quarterly Rebalance
- Corporate Presentation of Ph1b/2a DME Trial Data (ASRS)
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea